FHLC

Fidelity MSCI Health Care Index ETF

Fundamental data last updated:September 30, 2026

We may earn a commission from partner links. This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate.

company profile

SECTOR

Financial Services

industry

Asset Management - Global

Exchange

AMEX

County of HQ

US

Next Earnings Date

Not Scheduled

Business Summary

Tracks the performance of the MSCI USA IMI Health Care Index.

 


Analyze FHLC on TradingView

VALUATION

P/E

N/A

Market Cap ($M USD)

$2.90B

Forward P/E

N/A

PEG

N/A

PRICE TO SALES

N/A

PRICE TO BOOK

N/A

EV / EBITDA

N/A

5-Year Average P/E

Free Cash Flow Yield

N/A

DCF Value

N/A

Graham Number

N/A

Price to FCF

N/A

EV to FCF

N/A

Earnings Yield

N/A

FCF Yield

N/A

DIVIDEND

Yield

N/A

Annual Payout

N/A

Payout Ratio

N/A

Consecutive Years of Dividend Growth

5-Year Dividend Growth Rate

Financial Health & Profitability

Earnings Per Share

N/A

Next Year EPS Growth Estimate

N/A

Next Year Revenue Growth Estimate

N/A

Return on Equity (ROE)

N/A

FREE CASH FLOW

Operating Margin

N/A

Debt-to-Equity

N/A

Piotroski F-Score

N/A

Altman Z-Score

N/A

Return on Invested Capital (ROIC)

N/A

Current Ratio

N/A

Quick Ratio

N/A

Net Debt to EBITDA

N/A

Interest Coverage

N/A

Gross Profit margin

N/A

FCF PER SHARE

N/A

REVENUE PER SHARE

N/A

Analyze FHLC on TradingView

Gainseekers Quantitative Analysis

Summary

The absence of key valuation metrics like DCF Value and Graham Number leaves us in the dark about FHLC’s intrinsic worth. With no Forward P/E or Earnings Yield, the market’s growth expectations remain a mystery. The lack of an Altman Z-score further clouds any assessment of financial stability. The stock’s recent pricing, however, shows it trading below both its 50-Day and 200-Day SMAs, suggesting a potential undervaluation or market skepticism. Without concrete data, any verdict on its valuation is speculative at best.

AI Exposure / Tech Reliance

Operating in the Asset Management industry, FHLC is positioned to leverage AI for enhanced portfolio management and risk assessment. The sector's adaptability to tech shifts could drive efficiencies and improve client outcomes. However, the lack of specific data makes it challenging to quantify this potential.

The Bull Case

A value or GARP investor might find FHLC appealing due to its low 1-Year Beta of 0.64, indicating reduced volatility. This stability can be attractive in uncertain markets. However, without data on ROIC, FCF Yield, or Piotroski F-Score, it's difficult to build a compelling narrative around capital efficiency or pricing power.

The Bear Case

The glaring absence of fundamental metrics like Price/Book, Price/Sales, and cash flow figures raises red flags. Trading close to its 52-week high, the stock appears technically overextended. This lack of transparency in financial health metrics could deter risk-averse investors. The market may be pricing in optimism without the backing of solid financial data.

Market Sentiment & Smart Money

Short Interest %

Analyst Consensus

N/A

Average Analyst Price Target

N/A

Institutional Ownership %

1-Year Beta

0.64

Insider Buying % (6 Mo)

Distance to 52-Week High

5.88%

Distance to 52-Week Low

16.08%

EARNINGS SURPRISE %

N/A

50-DAY SMA

$70.51

200-DAY SMA

$71.16

⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.